We provide a comprehensive model for forecasting the critical transitional phases throughout the product cycle, covering launch, critical market changes, and LoE. Using cutting-edge data science and proprietary ontologies, we causatively link your specific context to past occurrences in the global pharmaceutical markets. This provides optimal forecasting fit and best possible market benchmark. The model compensates for list-price bias of most sales and market data and provides sensitivity analysis encompassing the full historical market knowledge.
UNBIASED MARKET INSIGHTS
We overcome the critical biases of list-price references and case bias, firstly by separating the volume and price analysis and secondly by including our Cortris 8-dimensional market correction to ensure accurate forecasting.
STRUCTURED AI MODELLING
We provide causality in our machine learning market modelling by anchoring the analysis in market specific structures – ensuring the analysis is guided by real market competition.
UNDERSTANDING IS KEY
We deliver a step-by-step causality and sensitivity analysis, allowing our partner full insight into the market dynamics driving their specific product forecast.
MARKET-ON-MARKET BESPOKE FORECASTING
